Post-transplant aspergillosis and the role of combined neurosurgical and antifungal therapies under belatacept immunosuppression

Opportunistic CNS-infection represent a major threat to patients after organ transplantation due to the need for ongoing immunosuppression and belatacept is a novel CTL4A inhibitor, which is increasingly used for patients following cadaveric kidney transplantation. Among the CNS infections, intracranial Aspergillus is a particular challenge and poses… CONTINUE READING